Selected Publications

Wolfram J, Shen H, Ferrari M (2015)
Multistage vector therapeutics.
Journal of Controlled Release (Accepted)

Deng Z, et al. (2015)
Circulating peptidome to indicate the tumor-resident proteolysis.
Scientific Reports 5:9327.

Blanco E, et al. (2014)
Co-localized delivery of rapamycin and paclitaxel to tumors enhances synergistic targeting of the PI3K/Akt/mTOR pathway.
Molecular Therapy 22(7):1310-9.

Dave B, et al. (2014)
Targeting RPL39 and MLF2 reduce tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling.
Proceedings of the National Academy of Sciences 111(24):8838-43.

Chen X, et al.  (2014)
XBP1 promotes triple negative breast cancer by controlling the HIF1α pathway.
Nature 508(7494):103-107.

Ferrari M (2013)
Problems in (nano) medical mechanics.
International Journal of Non-Linear Mechanics 56:3-19.

Parodi A, et al. (2013)
Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions.
Nature Nanotechnology 8(1): 61-68.

Hall R, Sun T, Ferrari M (2012)
A portrait of nanomedicine and its bioethical implications.
Journal of Law, Medicine & Ethics 40(4): 763-779.

Michor F, Liphardt J, Ferrari M, Widom J (2011)
What does physics have to do with cancer? [review, cover]
Nature Reviews Cancer 11(9):657-670.

Ananta JS, et al. (2010)
Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T1 contrast.
Nature Nanotechnology 5(11):815-821.

Ferrari M (2010)
Vectoring siRNA therapeutics into the clinic.
Nature Reviews in Clinical Oncology 7(9):485-6.

Evans J (2009)
Five big ideas for nanotechnology. 
Nature Medicine 15(4):348.

Ferrari M (2009).
Straight talk with... Mauro Ferrari. Interviewed by Jon Evans.
Nature Medicine 15(7):716-7.

Ferrari M, Philibert M, Sanhai W (2009).
Nanomedicine and society
Clinical Pharmacology & Therapeutics 85(5):466-7.

Gewin, V (2009).
Big opportunities in a small world.
Nature 460(7254):540-1.

Ferrari M (2008).
Nanogeometry: Beyond Drug Delivery
Nature Nanotechnology 3(3):131-132.

Sanhai W, Sakamoto J, Canady R, Ferrari M (2008).
Seven Challenges for Nanomedicine
Nature Nanotechnology(3):242-244.

Decuzzi P, Gentile F, Granaldi A, Curcio A, Causa F, Indolfi C, Netti P, Ferrari M (2007).
Flow Chamber Analysis of Size Effects in the Adhesion of Spherical Particles
International Journal of Nanomedicine.

Robertson F, Mallery S, Bergdahl-Costell V, Cheng M, Pei P, Prosperi J, Ferrari M (2007).
Cyclooxygenase-2 Directly Induces MCF-7 Breast Tumor Cells to Develop into Exponentially Growing, Highly Angiogenic and Regionally Invasive Ductal Carcinoma Xenografts
AntiCancer 27(2):719-27.

Amato F, et al. (2006).
Multiscale Modeling of Protein Transport In Silicon Membrane Nanochannels. Part 2. From Molecular Parameters to a Predictive Continuum Diffusion Model
Biomedical Microdevices 8(4):291-298.

Cheng M, et al. (2006).
Nanotechnologies for Biomolecular Detection and Medical Diagnostics
Current Opinion in Chemical Biology 10(1):11-19.

Sanga S, Sinek J, Frieboes H, Ferrari M, Fruehauf J, Christini V (2006).
Mathematical Modeling of Cancer Progression and Response to Chemotherapy
Expert Review Anticancer Therapy 6(10):1361-1376.

Decuzzi P, Lee S, Bhushan B, Ferrari M (2005).
A Theoretical Model for the Margination of Particles within Blood Vessels
Annals of Biomedical Engineering 33(2):179-190.

Ferrari M (2005).
Cancer nanotechnology: opportunities and challenges
Nature Reviews Cancer 5:161-171.

Liotta L, Ferrari M, and Petricoin E (2003).
Clinical proteomics: Written in blood
Nature 425:905.